Monday, January 23, 2006

Closed Session

8:00

Bias and Conflict Discussion

Susanne Stoiber

Executive Director, Institute of Medicine

Open Session

9:00

MIDRP Welcome

COL David Vaughn, MC

Director, Military Infectious Disease Research Program

Fort Detrick, Maryland

9:15

Chairman’s Remarks and Introductions

9:30

MIDRP and Malaria Program Overview and Review of Committee Charge

COL David Vaughn

10:30

Break

11:00

Overview Malaria Vaccine Development

Dr. Filip Dubovsky

Scientific Director, Malaria Vaccine Initiative

12:00

Lunch

1:00–5:15

Program Review—Protein-based vaccine strategy

1:00

Objectives and Strategy

COL Gray Heppner

1:30

Progress towards an RTS,S-Based Vaccine by Year 2010: New Adjuvants, Antigens, and Vectors

  • Status of RTS,S/AS02A

COL Gray Heppner

  • Adjuvant AS01B: RTS,S/AS02A vs. RTS,S/AS01B

COL Kent Kester

  • GMP Pf Antigens MSP-1, AMA-1, and LSA-1

Dr. Evelina Angov

  • Adenovirus 35 with circumsporozoite protein

Dr. Ann Stewart



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement